Smiling mature couple in natural setting
By Frank E. Kaden, D.C. Chiropractic, Inc.
If you suffer from fibromyalgia, you are not alone, as Dr. Kaden sees many patients with this particular condition in our Redondo Beach chiropractic clinic. As a matter of fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the United States have fibromyalgia. Thankfully, chiropractic is one treatment option that can provide positive results.
Research Proves Chiropractic Helps Fibromyalgia
In a paper released in mid-2015, 215 women and men with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression symptoms and anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal therapy program for three months and the second group receiving the same approach with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.
The individuals who received chiropractic adjustments in addition to the multi-modal therapy approach reported greater results in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study participants who received multi-modal therapy without chiropractic. Furthermore, those positive benefits were long-lasting as the subjects reported continued improvement one full year later.
Fibromyalgia can significantly decrease your quality of life, both mentally and physically. If you’re suffering from fibromyalgia, we might be able to help.
You don’t have to suffer! To find out what Dr. Kaden can do for your fibromyalgia pain, call our Redondo Beach chiropractic office today.
Sources
- Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
- Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.
